Please enable JavaScript to continue using this application.

Compare $BIO vs $RGEN | Chartloom

Compare

$BIO vs $RGEN

Bio Rad Laboratories Inc · Repligen Corp

BIO

Bio Rad Laboratories Inc

RGEN

Repligen Corp

Compare $BIO vs $RGEN

Comparing Bio Rad Laboratories Inc and Repligen Corp

BIOBio Rad Laboratories Inc

RGENRepligen Corp

BIOBio Rad Laboratories Inc

Market cap

$9.80B

P/E (TTM)

44.15x

Forward P/E (NTM)

33.67x

Forward P/S (NTM)

3.70x

Rev growth (TTM)

1.4%

YTD performance

19.9%

52W performance

20.9%

FCF yield

3.6%

RGENRepligen Corp

Market cap

$9.81B

P/E (TTM)

237.08x

Forward P/E (NTM)

75.08x

Forward P/S (NTM)

10.82x

Rev growth (TTM)

16.5%

YTD performance

5.8%

52W performance

15.3%

FCF yield

1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIO

RGEN

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

RGEN

Repligen Corp

Market Cap

BIO$9.80B

RGEN$9.81B

Enterprise Value

BIO$10.49B

RGEN$9.76B

Price

BIO$366.16

RGEN$173.88

P/E Ratio

BIO44.15x

RGEN237.08x

P/S Ratio

BIO3.78x

RGEN12.50x

EV/Sales

BIO4.05x

RGEN12.43x

EV/EBITDA

BIO15.48x

RGEN64.73x

P/B Ratio

BIO1.38x

RGEN4.86x

P/FCF Ratio

BIO27.75x

RGEN89.09x

EV/FCF

BIO29.69x

RGEN88.59x

PEG Ratio

BION/A

RGEN11.27x

Forward P/E (NTM)

BIO33.67x

RGEN75.08x

Forward P/S (NTM)

BIO3.70x

RGEN10.82x

Revenue (TTM)

BIO$2.59B

RGEN$785M

Revenue Growth (YoY)

BIO1.4%

RGEN16.5%

Forward Rev Growth

BIO2.9%

RGEN17.6%

Gross Margin (TTM)

BIO51.9%

RGEN53.8%

Operating Margin (TTM)

BIO1.8%

RGEN6.5%

EBITDA Margin (TTM)

BIO9.1%

RGEN18.8%

Net Margin (TTM)

BIO8.6%

RGEN5.3%

FCF Margin (TTM)

BIO13.6%

RGEN14.0%

Net Income (TTM)

BIO$222M

RGEN$42M

FCF (TTM)

BIO$353M

RGEN$110M

EPS (TTM)

BIO$8.29

RGEN$0.73

ROE (TTM)

BIO3.1%

RGEN2.0%

ROA (TTM)

BIO2.2%

RGEN1.4%

ROIC (TTM)

BIO2.7%

RGEN1.6%

Cash

BIO$517M

RGEN$607M

Debt

BIO$1.20B

RGEN$551M

Net Cash/Debt

BIO$-687M

RGEN$56M

Current Ratio (TTM)

BIO3.14x

RGEN9.05x

Quick Ratio (TTM)

BIO2.18x

RGEN7.30x

Debt/Equity (TTM)

BIO0.17x

RGEN0.26x

Debt/Assets (TTM)

BIO0.0%

RGEN0.0%

Interest Coverage (TTM)

BION/A

RGENN/A

Net Debt/EBITDA (TTM)

BIO0.00x

RGEN0.00x

Beta

BIO1.07

RGEN1.13

52W Performance

BIO20.9%

RGEN15.3%

YTD Performance

BIO19.9%

RGEN5.8%

% from 52W High

BIO-7.6%

RGEN-12.6%

% from 52W Low

BIO54.7%

RGEN72.2%

Asset Turnover (TTM)

BIO0.26x

RGEN0.27x

FCF Yield (TTM)

BIO3.6%

RGEN1.1%

Earnings Yield (TTM)

BIO2.3%

RGEN0.4%

Dividend Yield (TTM)

BION/A

RGENN/A

Rule of 40

BIO15.0

RGEN30.5

EV/GP/RG

BIO1.18

RGEN1.46

Ticker research

View BIO research View RGEN research

Metric	BIO Bio Rad Laboratories Inc	RGEN Repligen Corp
Market & Valuation
Market Cap	$9.80B	$9.81B
Enterprise Value	$10.49B	$9.76B
Price	$366.16	$173.88
P/E Ratio	44.15x	237.08x
P/S Ratio	3.78x	12.50x
EV/Sales	4.05x	12.43x
EV/EBITDA	15.48x	64.73x
P/B Ratio	1.38x	4.86x
P/FCF Ratio	27.75x	89.09x
EV/FCF	29.69x	88.59x
PEG Ratio	N/A	11.27x
Forward P/E (NTM)	33.67x	75.08x
Forward P/S (NTM)	3.70x	10.82x
Revenue & Growth
Revenue (TTM)	$2.59B	$785M
Revenue Growth (YoY)	1.4%	16.5%
Forward Rev Growth	2.9%	17.6%
Profitability
Gross Margin (TTM)	51.9%	53.8%
Operating Margin (TTM)	1.8%	6.5%
EBITDA Margin (TTM)	9.1%	18.8%
Net Margin (TTM)	8.6%	5.3%
FCF Margin (TTM)	13.6%	14.0%
Net Income (TTM)	$222M	$42M
FCF (TTM)	$353M	$110M
EPS (TTM)	$8.29	$0.73
ROE (TTM)	3.1%	2.0%
ROA (TTM)	2.2%	1.4%
ROIC (TTM)	2.7%	1.6%
Financial Health
Cash	$517M	$607M
Debt	$1.20B	$551M
Net Cash/Debt	$-687M	$56M
Current Ratio (TTM)	3.14x	9.05x
Quick Ratio (TTM)	2.18x	7.30x
Debt/Equity (TTM)	0.17x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.13
52W Performance	20.9%	15.3%
YTD Performance	19.9%	5.8%
% from 52W High	-7.6%	-12.6%
% from 52W Low	54.7%	72.2%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.27x
FCF Yield (TTM)	3.6%	1.1%
Earnings Yield (TTM)	2.3%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	15.0	30.5
EV/GP/RG	1.18	1.46
Ticker research	View BIO research	View RGEN research

Valuation

P/E Ratio

BIO

44.15x

RGEN

237.08x

P/S Ratio

BIO

3.78x

RGEN

12.50x

EV/FCF

BIO

29.69x

RGEN

88.59x

Growth & revenue

Revenue Growth TTM

RGEN

16.5%

BIO

1.4%

Forward Revenue Growth

RGEN

17.6%

BIO

2.9%

Profitability & performance

Gross Margin

RGEN

53.8%

BIO

51.9%

ROE

BIO

3.1%

RGEN

2.0%

FCF Yield %

BIO

3.6%

RGEN

1.1%

52-Week Performance

BIO

20.9%

RGEN

15.3%

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

RGEN

Repligen Corp

Market Cap

BIO$9.80B

RGEN$9.81B

Enterprise Value

BIO$10.49B

RGEN$9.76B

Price

BIO$366.16

RGEN$173.88

P/E Ratio

BIO44.15x

RGEN237.08x

P/S Ratio

BIO3.78x

RGEN12.50x

EV/Sales

BIO4.05x

RGEN12.43x

EV/EBITDA

BIO15.48x

RGEN64.73x

P/B Ratio

BIO1.38x

RGEN4.86x

P/FCF Ratio

BIO27.75x

RGEN89.09x

EV/FCF

BIO29.69x

RGEN88.59x

PEG Ratio

BION/A

RGEN11.27x

Forward P/E (NTM)

BIO33.67x

RGEN75.08x

Forward P/S (NTM)

BIO3.70x

RGEN10.82x

Revenue (TTM)

BIO$2.59B

RGEN$785M

Revenue Growth (YoY)

BIO1.4%

RGEN16.5%

Forward Rev Growth

BIO2.9%

RGEN17.6%

Gross Margin (TTM)

BIO51.9%

RGEN53.8%

Operating Margin (TTM)

BIO1.8%

RGEN6.5%

EBITDA Margin (TTM)

BIO9.1%

RGEN18.8%

Net Margin (TTM)

BIO8.6%

RGEN5.3%

FCF Margin (TTM)

BIO13.6%

RGEN14.0%

Net Income (TTM)

BIO$222M

RGEN$42M

FCF (TTM)

BIO$353M

RGEN$110M

EPS (TTM)

BIO$8.29

RGEN$0.73

ROE (TTM)

BIO3.1%

RGEN2.0%

ROA (TTM)

BIO2.2%

RGEN1.4%

ROIC (TTM)

BIO2.7%

RGEN1.6%

Cash

BIO$517M

RGEN$607M

Debt

BIO$1.20B

RGEN$551M

Net Cash/Debt

BIO$-687M

RGEN$56M

Current Ratio (TTM)

BIO3.14x

RGEN9.05x

Quick Ratio (TTM)

BIO2.18x

RGEN7.30x

Debt/Equity (TTM)

BIO0.17x

RGEN0.26x

Debt/Assets (TTM)

BIO0.0%

RGEN0.0%

Interest Coverage (TTM)

BION/A

RGENN/A

Net Debt/EBITDA (TTM)

BIO0.00x

RGEN0.00x

Beta

BIO1.07

RGEN1.13

52W Performance

BIO20.9%

RGEN15.3%

YTD Performance

BIO19.9%

RGEN5.8%

% from 52W High

BIO-7.6%

RGEN-12.6%

% from 52W Low

BIO54.7%

RGEN72.2%

Asset Turnover (TTM)

BIO0.26x

RGEN0.27x

FCF Yield (TTM)

BIO3.6%

RGEN1.1%

Earnings Yield (TTM)

BIO2.3%

RGEN0.4%

Dividend Yield (TTM)

BION/A

RGENN/A

Rule of 40

BIO15.0

RGEN30.5

EV/GP/RG

BIO1.18

RGEN1.46

Ticker research

View BIO research View RGEN research

Metric	BIO Bio Rad Laboratories Inc	RGEN Repligen Corp
Market & Valuation
Market Cap	$9.80B	$9.81B
Enterprise Value	$10.49B	$9.76B
Price	$366.16	$173.88
P/E Ratio	44.15x	237.08x
P/S Ratio	3.78x	12.50x
EV/Sales	4.05x	12.43x
EV/EBITDA	15.48x	64.73x
P/B Ratio	1.38x	4.86x
P/FCF Ratio	27.75x	89.09x
EV/FCF	29.69x	88.59x
PEG Ratio	N/A	11.27x
Forward P/E (NTM)	33.67x	75.08x
Forward P/S (NTM)	3.70x	10.82x
Revenue & Growth
Revenue (TTM)	$2.59B	$785M
Revenue Growth (YoY)	1.4%	16.5%
Forward Rev Growth	2.9%	17.6%
Profitability
Gross Margin (TTM)	51.9%	53.8%
Operating Margin (TTM)	1.8%	6.5%
EBITDA Margin (TTM)	9.1%	18.8%
Net Margin (TTM)	8.6%	5.3%
FCF Margin (TTM)	13.6%	14.0%
Net Income (TTM)	$222M	$42M
FCF (TTM)	$353M	$110M
EPS (TTM)	$8.29	$0.73
ROE (TTM)	3.1%	2.0%
ROA (TTM)	2.2%	1.4%
ROIC (TTM)	2.7%	1.6%
Financial Health
Cash	$517M	$607M
Debt	$1.20B	$551M
Net Cash/Debt	$-687M	$56M
Current Ratio (TTM)	3.14x	9.05x
Quick Ratio (TTM)	2.18x	7.30x
Debt/Equity (TTM)	0.17x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.13
52W Performance	20.9%	15.3%
YTD Performance	19.9%	5.8%
% from 52W High	-7.6%	-12.6%
% from 52W Low	54.7%	72.2%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.27x
FCF Yield (TTM)	3.6%	1.1%
Earnings Yield (TTM)	2.3%	0.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	15.0	30.5
EV/GP/RG	1.18	1.46
Ticker research	View BIO research	View RGEN research